<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Dierckx L</submitter><funding>Universiteit Antwerpen (UAntwerp)</funding><funding>Universiteit Antwerpen</funding><pagination>e0169624</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11980397</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>63(4)</volume><pubmed_abstract>&lt;i>Streptococcus pneumoniae&lt;/i> serotype 23B, a non-vaccine serotype, has shown an increasing prevalence and penicillin non-susceptibility among carriage and invasive pneumococcal disease (IPD) isolates. Recently, a novel penicillin non-susceptible genotype has emerged, named 23B1. In the framework of the Belgian pneumococcal carriage study, we studied the prevalence of 23B&lt;sub>0&lt;/sub>/23B1 among 586 23B strains (2016-2022) in 172 day care centers from 6- to 30-month-old children and among 130 pediatric 23B IPD isolates (2007-2021). Pneumococci were whole genome sequenced to determine the capsular polysaccharide genotype and sequence type (ST). Antimicrobial susceptibility testing determined penicillin and amoxicillin MICs, as well as resistance to co-trimoxazole and levofloxacin. 23B carr</pubmed_abstract><journal>Journal of clinical microbiology</journal><pubmed_title>Pneumococcal genotype 23B1 as a driver of increased 23B serotype carriage, penicillin non-susceptibility, and invasive disease in Belgium: a retrospective analysis.</pubmed_title><pmcid>PMC11980397</pmcid><funding_grant_id>VAX-Idea Methusalem funds</funding_grant_id><pubmed_authors>Cuypers L</pubmed_authors><pubmed_authors>Beutels P</pubmed_authors><pubmed_authors>Ekinci E</pubmed_authors><pubmed_authors>Maertens K</pubmed_authors><pubmed_authors>Dierckx L</pubmed_authors><pubmed_authors>Willen L</pubmed_authors><pubmed_authors>Rodriguez-Ruiz JP</pubmed_authors><pubmed_authors>Malhotra-Kumar S</pubmed_authors><pubmed_authors>van Heirstraeten L</pubmed_authors><pubmed_authors>Theeten H</pubmed_authors><pubmed_authors>Desmet S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Pneumococcal genotype 23B1 as a driver of increased 23B serotype carriage, penicillin non-susceptibility, and invasive disease in Belgium: a retrospective analysis.</name><description>&lt;i>Streptococcus pneumoniae&lt;/i> serotype 23B, a non-vaccine serotype, has shown an increasing prevalence and penicillin non-susceptibility among carriage and invasive pneumococcal disease (IPD) isolates. Recently, a novel penicillin non-susceptible genotype has emerged, named 23B1. In the framework of the Belgian pneumococcal carriage study, we studied the prevalence of 23B&lt;sub>0&lt;/sub>/23B1 among 586 23B strains (2016-2022) in 172 day care centers from 6- to 30-month-old children and among 130 pediatric 23B IPD isolates (2007-2021). Pneumococci were whole genome sequenced to determine the capsular polysaccharide genotype and sequence type (ST). Antimicrobial susceptibility testing determined penicillin and amoxicillin MICs, as well as resistance to co-trimoxazole and levofloxacin. 23B carr</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Apr</publication><modification>2025-07-05T03:04:30.402Z</modification><creation>2025-07-05T03:04:30.402Z</creation></dates><accession>S-EPMC11980397</accession><cross_references><pubmed>40071954</pubmed><doi>10.1128/jcm.01696-24</doi></cross_references></HashMap>